<DOC>
	<DOCNO>NCT03094715</DOCNO>
	<brief_summary>TENSION ( Efficacy safety ThrombEctomy iN Stroke extend leSION extend time window ) prospective , open label , blind endpoint ( PROBE ) , European two-arm , randomize , control , post-market study compare safety effectiveness endovascular thrombectomy compare best medical care alone treatment acute ischemic stroke patient extend stroke lesion define Alberta Stroke Program Early CT Score ( ASPECTS ) score 3-5 extended time window ( 12 hour unknown time symptom onset ) . Up 714 subject randomize . Primary endpoint functional outcome assess modified Rankin scale 90 day post-stroke ( `` mRS shift analysis '' ) . By , TENSION provide evidence efficacy safety thrombectomy acute stroke population uncertain benefit endovascular stroke treatment .</brief_summary>
	<brief_title>Efficacy Safety Thrombectomy Stroke With Extended Lesion Extended Time Window</brief_title>
	<detailed_description>This study prospective , open label , blind endpoint ( PROBE ) , European , two-arm , randomize , control , post-market study compare safety effectiveness endovascular thrombectomy compare best medical care alone treatment acute ischemic stroke ( AIS ) patient extend stroke lesion define ASPECT score 3-5 extended time window ( 12 hour , unknown time symptom onset ) . This adaptive design study , prospectively state interim analysis specify stop rule allow possibility early termination base either determination study success futility . Up 714 subject enrol study randomize Intention treat analysis set . The randomization stratify time symptom onset ( 0-6h 6-11h/wake stroke ) , stroke severity ( NIHSS â‰¤18 , NIHSS &gt; 18 ) . Interim data analysis plan primary endpoint obtain one third two third patient . At sample size , available 90-day mRS data treatment arm evaluate . Safety interim analysis perform one third two third patient include . Subjects meet inclusion criterion randomize 1:1 ratio one follow two treatment arm : Arm 1 : best medical care Arm 2 : endovascular thrombectomy best medical care The primary objective study test efficacy safety thrombectomy acute stroke patient uncertain benefit endovascular stroke treatment , i.e . extend ischemic lesion size ASPECT score 3-5 late ( 12 hour ) unknown time window compare best medical care alone . Approximately 40 site Up 20 site 8-10 European country Patients present acute ischemic stroke ( AIS ) base focal occlusion M1 segment middle cerebral artery ( MCA ) , and/or intracranial segment distal internal carotid artery ( ICA ) , determine Magnetic Resonance Angiography ( MRA ) Computed Tomographic Angiography ( CTA ) , meet eligibility criterion consider study enrollment .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Moderate severe stroke ( NIHSS &lt; 26 ) Premorbid mRS 02 Life expectancy &gt; 6 month Treatment accomplish within 12 hour stroke onset ( know ) , i.e . randomization within 11 hour ictus Informed consent patient , legal guardian , inclusion patient presumptive consultation independent physician statement investigator Imaging inclusion criterion Occlusion M1 segment middle cerebral artery ( MCA ) , and/or intracranial segment distal internal carotid artery ( ICA ) , determine Magnetic Resonance Angiography ( MRA ) Computed Tomographic Angiography ( CTA ) CT ( noncontrastCT ) diffusion weight imaging ( DWI ) ASPECT score 35</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Mechanical thrombectomy</keyword>
	<keyword>Endovascular thrombectomy</keyword>
</DOC>